{"id":"NCT01159015","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers","officialTitle":"A Multi-center, Double-masked, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy, Normal Volunteers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2010-09","completion":"2010-10","firstPosted":"2010-07-09","resultsPosted":"2020-09-14","lastUpdate":"2020-10-05"},"enrollment":534,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"SCREENING"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"KetoNaph","otherNames":[]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"KetoNaph","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to evaluate the safety of KetoNaph ophthalmic solution in healthy adult subjects and in pediatric subjects with a history or family history of ocular allergy.","primaryOutcome":{"measure":"Percentage of Participants With at Least One Adverse Event.","timeFrame":"42 days","effectByArm":[{"arm":"KetoNaph","deltaMin":113,"sd":null},{"arm":"Vehicle","deltaMin":34,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":357},"commonTop":["Eye Irritation"]}}